{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:10:04Z","timestamp":1756656604090,"version":"3.44.0"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Domestic Animal Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.domaniend.2025.106955","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T01:53:45Z","timestamp":1747533225000},"page":"106955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bridging the gap\u2014Rethinking the role of the adrenal gland in chronic kidney disease from the feline perspective"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-134X","authenticated-orcid":false,"given":"Patricia Lunet","family":"Marques","sequence":"first","affiliation":[]},{"given":"Sara","family":"Galac","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Mateus","sequence":"additional","affiliation":[]},{"given":"Rodolfo Oliveira","family":"Leal","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1098612X14536176","article-title":"Longevity and mortality of cats attending primary care veterinary practices in England","volume":"17","author":"O\u2019Neill","year":"2015","journal-title":"J Feline Med Surg"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0300985815622975","article-title":"Chronic kidney disease in aged cats: clinical features, morphology, and proposed pathogeneses","volume":"53","author":"Brown","year":"2016","journal-title":"Vet Pathol"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0003","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1098612X16631234","article-title":"ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease","volume":"18","author":"Sparkes","year":"2016","journal-title":"J Feline Med Surg"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0004","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/jvim.13917","article-title":"Risk factors for development of chronic kidney disease in cats","volume":"30","author":"Finch","year":"2016","journal-title":"J Vet Intern Med"},{"issue":"1_suppl","key":"10.1016\/j.domaniend.2025.106955_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1098612X13495241","volume":"15","author":"Korman","year":"2013","journal-title":"J Feline Med Surg"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0006","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1939-1676.2011.00874.x","article-title":"Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease","volume":"26","author":"Chakrabarti","year":"2012","journal-title":"J Vet Intern Med"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0021-9975(96)80082-X","article-title":"The renin-angiotensin system in cats withchronic renal failure","volume":"115","author":"Taugner","year":"1996","journal-title":"J Comp Pathol"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0008","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2460\/ajvr.1997.58.05.535","article-title":"Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease","volume":"58","author":"Jensen","year":"1997","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0009","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jvim.12240","article-title":"Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate","volume":"28","author":"Jepson","year":"2014","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2025.106955_bib0010","unstructured":"Glucocorticoid receptor - endotext - NCBI bookshelf. Accessed September 30, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279171\/."},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygcen.2010.07.004","article-title":"Cushing\u2019s syndrome, glucocorticoids and the kidney","volume":"169","author":"Smets","year":"2010","journal-title":"Gen Comp Endocr"},{"key":"10.1016\/j.domaniend.2025.106955_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1075809","article-title":"Cortisol excess in chronic kidney disease \u2013 a review of changes and impact on mortality","volume":"13","author":"Sagmeister","year":"2023","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0013","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/jvim.15331","article-title":"ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"32","author":"Acierno","year":"2018","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1939-1676.2011.00838.x","article-title":"Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats","volume":"26","author":"Freeman","year":"2012","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2025.106955_bib0015","unstructured":"Basic endocrinological disorders in chronic renal failure | Niemczyk | Endokrynologia Polska. Accessed September 30, 2024. https:\/\/journals.viamedica.pl\/endokrynologia_polska\/article\/view\/25177\/20006."},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0016","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0017","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1373\/clinchem.2003.029934","article-title":"Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0018","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/cen.13889","article-title":"Glucocorticoid activation by 11\u03b2-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: a cross-sectional study","volume":"90","author":"Sagmeister","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0019","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/eje.1.01954","article-title":"Expression of renal 11\u03b2-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function","volume":"153","author":"Quinkler","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/jcem-50-1-46","article-title":"Pituitary-adrenocortical function in chronic renal failure: studies of episodic secretion of cortisol and dexamethasone suppressibility*","volume":"50","author":"Wallace","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0021","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1042\/BST20210419","article-title":"Structural insights into glucocorticoid receptor function","volume":"49","author":"Frank","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.domaniend.2025.106955_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105952","article-title":"The clinical significance of the glucocorticoid receptors: genetics and epigenetics","volume":"213","author":"Motavalli","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0023","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","article-title":"Non-genomic effects of glucocorticoids: an updated view","volume":"40","author":"Panettieri","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0024","doi-asserted-by":"crossref","first-page":"F781","DOI":"10.1152\/ajprenal.1993.264.5.F781","article-title":"Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron","volume":"264","author":"Todd-Turla","year":"1993","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1523-1755.1999.00503.x","article-title":"Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus","volume":"56","author":"Yan","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0026","doi-asserted-by":"crossref","first-page":"F672","DOI":"10.1152\/ajprenal.1990.259.4.F672","article-title":"Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells","volume":"259","author":"Naray-Fejes-Toth","year":"1990","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"10","key":"10.1016\/j.domaniend.2025.106955_bib0027","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/ndt\/gfab016","article-title":"The podocyte as a direct target of glucocorticoids in nephrotic syndrome","volume":"37","author":"Broek","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"1\u20132","key":"10.1016\/j.domaniend.2025.106955_bib0028","first-page":"20","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.domaniend.2025.106955_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9966372","article-title":"Suppression of adenosine deaminase and xanthine oxidase activities by mineralocorticoid and glucocorticoid receptor blockades restores renal antioxidative barrier in oral contraceptive-treated dam","volume":"2021","author":"Badmus","year":"2021","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0030","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai","year":"2018","journal-title":"J Immunol Res"},{"issue":"13\u201314","key":"10.1016\/j.domaniend.2025.106955_bib0031","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cca.2011.03.016","article-title":"Analysis of cortisol, cortisone and dexamethasone in human serum using liquid chromatography tandem mass spectrometry and assessment of cortisol: cortisone ratios in patients with impaired kidney function","volume":"412","author":"Ray","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"1\u20132","key":"10.1016\/j.domaniend.2025.106955_bib0032","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/07435809509030436","article-title":"Study on the mechanisms of glucocorticoid-induced hypertension: glucocorticoids increase transmembrane Ca2+ influx in vascular smooth muscle in vivo","volume":"21","author":"Kornel","year":"1995","journal-title":"Endocr Res"},{"issue":"7","key":"10.1016\/j.domaniend.2025.106955_bib0033","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00467-011-1928-4","article-title":"Glucocorticoid-induced hypertension","volume":"27","author":"Goodwin","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1291\/hypres.19.1","article-title":"Mechanism of glucocorticoid-induced hypertension","volume":"19","author":"Saruta","year":"1996","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.HYP.13.5.416","article-title":"Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function","volume":"13","author":"Sudhir","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0036","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000446965","article-title":"Metabolic and hormonal determinants of glomerular filtration rate and renal hemodynamics in severely obese individuals","volume":"9","author":"Vitolo","year":"2016","journal-title":"Obes Facts"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0037","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000443435","article-title":"Association between serum cortisol and chronic kidney disease in patients with essential hypertension","volume":"41","author":"Li","year":"2016","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/vhrm.2005.1.4.291","article-title":"Cardiovascular consequences of cortisol excess","volume":"1","author":"Whitworth","year":"2005","journal-title":"Vasc Heal Risk Manag"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0039","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.EJ15-0360","article-title":"Hypothalamic-pituitary-adrenal axis activity is associated with the prevalence of chronic kidney disease in diabetic patients","volume":"63","author":"Asao","year":"2016","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cen.13023","article-title":"Dynamics of salivary cortisol in chronic kidney disease patients at stages 1 through 4","volume":"85","author":"Cardoso","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0041","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00002480-197700230-00190","article-title":"Simplified assessment of pituitary\u2014adrenal axis in a stable group of chronic hemodialysis patients","volume":"23","author":"Akmal","year":"1977","journal-title":"ASAIO J"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0042","doi-asserted-by":"crossref","first-page":"bvae002","DOI":"10.1210\/jendso\/bvae002","article-title":"Overnight 1-mg DST serum cortisol in various stages of chronic kidney disease\u2014normative data and underlying mechanisms","volume":"8","author":"Garg","year":"2024","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0043","article-title":"Reserva funcional adrenal en el espectro completo de la enfermedad renal cr\u00f3nica","volume":"157","author":"Rodr\u00edguez-Guti\u00e9rrez","year":"2021","journal-title":"Gac Mxico"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0044","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1081\/JDI-100103495","article-title":"The hormonal and radiological evaluation of adrenal glands, and THE determination of THE usefulness of low dose acth test in patients with renal amyloidosis","volume":"23","author":"Kurto\u011flu","year":"2001","journal-title":"Ren Fail"},{"issue":"7","key":"10.1016\/j.domaniend.2025.106955_bib0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF03347016","article-title":"The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitaryadrenal insufficiency in patients with end-stage kidney disease","volume":"26","author":"Oguz","year":"2003","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0046","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000045132","article-title":"Paper chromatography prior to Cortisol RIA allows for accurate use of the dexamethasone suppression test in chronic renal failure","volume":"80","author":"Herle","year":"1998","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0047","first-page":"1238","article-title":"Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone","volume":"80","author":"Vermes","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2460\/javma.233.1.87","article-title":"Pituitary-adrenal function in dogs with acute critical illness","volume":"233","author":"Martin","year":"2008","journal-title":"J Am Vet Med Assoc"},{"issue":"s3","key":"10.1016\/j.domaniend.2025.106955_bib0049","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2362.2000.0300s3091.x","article-title":"The role of interleukin-6 in the human adrenal gland","volume":"30","author":"P\u00e4th","year":"2000","journal-title":"Eur J Clin Investig"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1010626608498","article-title":"Measurement of faecal cortisol metabolites in cats and dogs: a non-invasive method for evaluating adrenocortical function","volume":"25","author":"Schatz","year":"2001","journal-title":"Vet Res Commun"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0051","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1040638716671978","article-title":"Adrenal function in cats with cholestatic liver disease","volume":"29","author":"Buckley","year":"2017","journal-title":"J Vet Diagn Invest"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0052","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1939-1676.2000.tb01494.x","article-title":"Metabolic and hormonal alterations in cats with hepatic lipidosis","volume":"14","author":"Brown","year":"2000","journal-title":"J Vet Intern Med"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0053","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1098612X11435893","article-title":"Adrenal function in cats with hyperthyroidism","volume":"14","author":"Ramspott","year":"2011","journal-title":"J Feline Med Surg"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0054","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1939-1676.1996.tb02043.x","article-title":"Urine cortisol: creatinine ratio in healthy and sick cats","volume":"10","author":"Henry","year":"1996","journal-title":"J Vet Intern Med"},{"issue":"8","key":"10.1016\/j.domaniend.2025.106955_bib0055","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/1098612X16664390","article-title":"Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands","volume":"19","author":"Schaefer","year":"2017","journal-title":"J Feline Med Surg"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0056","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2460\/ajvr.1987.48.03.451","article-title":"Effect of nonadrenal illness on adrenal function in the cat","volume":"48","author":"Zerbe","year":"1987","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2024.2407174","article-title":"Evaluation of chronic stress status and quality of life in cats suffering from chronic kidney disease and suspected feline infectious peritonitis based on hair cortisol concentration analysis and a questionnaire","volume":"44","author":"Chen","year":"2024","journal-title":"Vet Q"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0058","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0289","article-title":"Recycling glucocorticoids: therapeutic implications of the 11\u03b2-HSD1 enzyme system","volume":"258","author":"Tsai","year":"2023","journal-title":"J Endocrinol"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0059","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1046\/j.1523-1755.2002.00308.x","article-title":"Increased cortisol metabolites and reduced activity of 11\u03b2-hydroxysteroid dehydrogenase in patients on hemodialysis","volume":"61","author":"N\u2019Gankam","year":"2002","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.domaniend.2025.106955_bib0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/meta.2001.24213","article-title":"Assessing systemic 11[beta]-hydroxysteroid dehydrogenase with serum cortisone\/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure","volume":"50","author":"Homma","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.domaniend.2025.106955_bib0061","first-page":"dgae663","article-title":"Progressive 11\u03b2-hydroxysteroid dehydrogenase type 2 insufficiency as kidney function declines","author":"Uslar","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.domaniend.2025.106955_bib0062","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11\u201312","key":"10.1016\/j.domaniend.2025.106955_bib0063","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.lfs.2008.07.005","article-title":"Differential regulation of 11\u03b2-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells","volume":"83","author":"Tsugita","year":"2008","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0064","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbadis.2003.11.003","article-title":"Characterisation of 11\u03b2-hydroxysteroid dehydrogenases in feline kidney and liver","volume":"1688","author":"Schipper","year":"2004","journal-title":"Biochim Et Biophys Acta Bba - Mol Basis Dis"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0065","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jfms.2008.10.004","article-title":"Urinary cortisol\/cortisone ratios in hypertensive and normotensive cats\u22c6","volume":"11","author":"Walker","year":"2008","journal-title":"J Feline Med Surg"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0066","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-016-9591-2","article-title":"Genomic and rapid effects of aldosterone: what we know and do not know thus far","volume":"22","author":"Hermidorff","year":"2017","journal-title":"Hear Fail Rev"},{"issue":"99","key":"10.1016\/j.domaniend.2025.106955_bib0067","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1523-1755.2005.09911.x","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","volume":"68","author":"Remuzzi","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0068","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.kisu.2021.11.004","article-title":"Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease","volume":"12","author":"Nakamura","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.domaniend.2025.106955_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107796","article-title":"Vascular mineralocorticoid receptor activation and disease","volume":"188","author":"Barrera-Chimal","year":"2019","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.kint.2018.08.024","article-title":"Aldosterone induces albuminuria via matrix metalloproteinase\u2013dependent damage of the endothelial glycocalyx","volume":"95","author":"Butler","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0071","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.ATV.0000258414.59393.89","article-title":"Mineralocorticoid receptor activation promotes vascular cell calcification","volume":"27","author":"Jaffe","year":"2007","journal-title":"Arter Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.domaniend.2025.106955_bib0072","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Investig"},{"issue":"10","key":"10.1016\/j.domaniend.2025.106955_bib0073","doi-asserted-by":"crossref","first-page":"bqad127","DOI":"10.1210\/endocr\/bqad127","article-title":"The mineralocorticoid receptor plays a crucial role in macrophage development and function","volume":"164","author":"Faught","year":"2023","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269920","article-title":"Increased glucocorticoid metabolism in diabetic kidney disease","volume":"17","author":"Ackermann","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.domaniend.2025.106955_bib0075","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1210\/en.2007-0209","article-title":"Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid\/salt administration?","volume":"148","author":"Rickard","year":"2007","journal-title":"Endocrinology"},{"issue":"38","key":"10.1016\/j.domaniend.2025.106955_bib0076","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/eurheartj\/ehac352","article-title":"Aldosterone in chronic kidney disease and renal outcomes","volume":"43","author":"Verma","year":"2022","journal-title":"Eur Hear J"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0077","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease","author":"Bolignano","year":"2014","journal-title":"Cochr Database Syst Rev"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0078","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11255-019-02074-9","article-title":"Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes","volume":"51","author":"Dong","year":"2019","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0079","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.120.051898","article-title":"Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes","volume":"143","author":"Filippatos","year":"2021","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.domaniend.2025.106955_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","article-title":"New aspects of rapid aldosterone signaling","volume":"308","author":"Grossmann","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0081","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexcr.2016.06.009","article-title":"Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney","volume":"346","author":"Sheng","year":"2016","journal-title":"Exp Cell Res"},{"issue":"12","key":"10.1016\/j.domaniend.2025.106955_bib0082","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.2023.16029","article-title":"Aldosterone synthase inhibition with Lorundrostat for uncontrolled hypertension","volume":"330","author":"Laffin","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.domaniend.2025.106955_bib0083","article-title":"A feline-focused review of chronic kidney disease-mineral and bone disorders \u2014 part 1: physiology of calcium handling","volume":"275","author":"Tang","year":"2021","journal-title":"Vet J"},{"key":"10.1016\/j.domaniend.2025.106955_bib0084","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22636.1","article-title":"Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease","volume":"9","author":"Rodr\u00edguez-Ortiz","year":"2020","journal-title":"F1000Research"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jvim.12044","article-title":"Fibroblast growth factor 23 in feline chronic kidney disease","volume":"27","author":"Geddes","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0086","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jvim.13625","article-title":"Relationship between plasma fibroblast growth factor-23 concentration and survival time in cats with chronic kidney disease","volume":"29","author":"Geddes","year":"2015","journal-title":"J Vet Intern Med"},{"issue":"23","key":"10.1016\/j.domaniend.2025.106955_bib0087","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0088","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031260","article-title":"Biology of fibroblast growth factor 23: from physiology to pathology","volume":"8","author":"Courbebaisse","year":"2018","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0089","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","article-title":"FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2\u2013SGK1 signaling pathway","volume":"51","author":"Andrukhova","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.domaniend.2025.106955_bib0091","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/1098612X211039192","article-title":"Serum fibroblast growth factor-23 concentrations in young and mature adult cats with chronic kidney disease","volume":"24","author":"Miyakawa","year":"2022","journal-title":"J Feline Med Surg"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0092","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1040638720985563","article-title":"Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease","volume":"33","author":"Lin","year":"2021","journal-title":"J Vet Diagn Investig"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0093","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jvim.12036","article-title":"Fibroblast growth factor 23 (FGF-23) concentrations in cats with early nonazotemic chronic kidney disease (CKD) and in healthy geriatric cats","volume":"27","author":"Finch","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0094","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","article-title":"Up-regulation of FGF23 release by aldosterone","volume":"470","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.domaniend.2025.106955_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.649921","article-title":"Aldosterone is positively associated with circulating FGF23 levels in chronic kidney disease across four species, and may drive FGF23 secretion directly","volume":"12","author":"Radloff","year":"2021","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0096","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/jvim.15141","article-title":"Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease","volume":"32","author":"Broek","year":"2018","journal-title":"J Vet Intern Med"},{"issue":"7","key":"10.1016\/j.domaniend.2025.106955_bib0097","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc12-0226","article-title":"Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease","volume":"35","author":"Sakaguchi","year":"2012","journal-title":"Diab Care"},{"key":"10.1016\/j.domaniend.2025.106955_bib0098","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1363975","article-title":"Magnesium in hypertension: mechanisms and clinical implications","volume":"15","author":"AlShanableh","year":"2024","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0099","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/jvim.17134","article-title":"Dietary magnesium supplementation in cats with chronic kidney disease: a prospective double-blind randomized controlled trial","volume":"38","author":"Tang","year":"2024","journal-title":"J Vet Intern Med"},{"issue":"9","key":"10.1016\/j.domaniend.2025.106955_bib0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jfms.2011.07.017","article-title":"Primary hyperaldosteronism","volume":"13","author":"Djajadiningrat-Laanen","year":"2011","journal-title":"J Feline Med Surg"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0101","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jvim.16741","article-title":"Prospective evaluation of a telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats","volume":"37","author":"Kurtz","year":"2023","journal-title":"J Vet Intern Med"},{"issue":"12","key":"10.1016\/j.domaniend.2025.106955_bib0102","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1161\/HYPERTENSIONAHA.124.23501","article-title":"Somatic GNAQ, CTNNB1, and CACNA1C mutations in cat aldosterone-secreting tumors","volume":"81","author":"Watson","year":"2024","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.domaniend.2025.106955_bib0103","first-page":"1226","article-title":"Effects of plasma aldosterone concentration and treatment with eplerenone on the survival of cats with chronic kidney disease","volume":"63","author":"Kai","year":"2022","journal-title":"Can Vet J Rev Veterinaire Can"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0104","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jn\/129.2.419","article-title":"Sodium requirement of adult cats for maintenance based on plasma aldosterone concentration 1, 2","volume":"129","author":"Yu","year":"1999","journal-title":"J Nutr"},{"issue":"8","key":"10.1016\/j.domaniend.2025.106955_bib0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/vetsci9080420","article-title":"Ultrasonographic detected adrenomegaly in clinically ill cats: a retrospective study","volume":"9","author":"Oliveira","year":"2022","journal-title":"Vet Sci"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.domaniend.2004.06.010","article-title":"Primary hyperaldosteronism, a mediator of progressive renal disease in cats","volume":"28","author":"Javadi","year":"2005","journal-title":"Domest Anim Endocrin"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1098612X20979509","article-title":"Feline abdominal ultrasonography: what\u2019s normal? What\u2019s abnormal? The adrenal glands","volume":"23","author":"Griffin","year":"2021","journal-title":"J Feline Med Surg"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anicom.2013.12.002","article-title":"Ultrasonographic examination of the feline adrenal glands: a review","volume":"49","author":"Combes","year":"2014","journal-title":"Rev V\u00e9t\u00e9rinaire Clin"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0109","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/jvim.12216","article-title":"Evaluation of the oral fludrocortisone suppression test for diagnosing primary hyperaldosteronism in cats","volume":"27","author":"Djajadiningrat-Laanen","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"12","key":"10.1016\/j.domaniend.2025.106955_bib0110","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2460\/javma.2002.220.1799","article-title":"Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation","volume":"220","author":"Syme","year":"2002","journal-title":"J Am Vet M\u00e9d Assoc"},{"key":"10.1016\/j.domaniend.2025.106955_bib0111","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clinms.2018.06.002","article-title":"Migration from RIA to LC-MS\/MS for aldosterone determination: implications for clinical practice and determination of plasma and urine reference range intervals in a cohort of healthy Belgian subjects","volume":"9","author":"Goff","year":"2018","journal-title":"Clin Mass Spectrom"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2460\/ajvr.2001.62.375","article-title":"Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency","volume":"62","author":"Brown","year":"2001","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0113","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2460\/ajvr.2002.63.833","article-title":"Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency","volume":"63","author":"Mathur","year":"2002","journal-title":"Am J Vet Res"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0114","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.HYP.23.4.531","article-title":"Salt sensitivity in hypertension. Renal and cardiovascular implications","volume":"23","author":"Campese","year":"2018","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.domaniend.2025.106955_bib0115","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ajh.2009.167","article-title":"Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans","volume":"22","author":"Kidambi","year":"2009","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0116","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1939-1676.2004.tb02567.x","article-title":"Dietary NaCl does not affect blood pressure in healthy cats","volume":"18","author":"Luckschander","year":"2004","journal-title":"J Vet Intern Med"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0117","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/jvim.13639","article-title":"Comparison of efficacy of long-term oral treatment with telmisartan and benazepril in cats with chronic kidney disease","volume":"29","author":"Sent","year":"2015","journal-title":"J Vet Intern Med"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0118","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jvim.15394","article-title":"Efficacy of long-term oral telmisartan treatment in cats with hypertension: results of a prospective European clinical trial","volume":"33","author":"Glaus","year":"2019","journal-title":"J Vet Intern Med"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0119","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/jvim.15429","article-title":"Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: results of a double-blind, placebo-controlled, randomized clinical trial","volume":"33","author":"Coleman","year":"2019","journal-title":"J Vet Intern Med"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0120","doi-asserted-by":"crossref","first-page":"H1219","DOI":"10.1152\/ajpheart.00796.2011","article-title":"The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome","volume":"302","author":"Putnam","year":"2012","journal-title":"Am J Physiol-Hear Circ Physiol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0121","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/srep08116","article-title":"Suppression of adrenal \u03b2arrestin1-dependent aldosterone production by ARBs: head-to-head comparison","volume":"5","author":"Dabul","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0122","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cvr\/cvn064","article-title":"Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization","volume":"79","author":"Yamada","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0123","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1476-5381.2012.02194.x","article-title":"Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications","volume":"168","author":"Toda","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0124","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jvim.14839","article-title":"Group the KCS. A double-blind, placebo-controlled, multicenter, prospective, randomized study of beraprost sodium treatment for cats with chronic kidney disease","volume":"32","author":"Takenaka","year":"2018","journal-title":"J Vet Intern Med"},{"issue":"2 Suppl","key":"10.1016\/j.domaniend.2025.106955_bib0125","first-page":"28","article-title":"Novel effects of beraprost sodium on vasculatures","volume":"29","author":"Sugawara","year":"2010","journal-title":"Int Angiol : J Int Union Angiol."},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0126","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.RES.0000091336.55487.F7","article-title":"Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells","volume":"93","author":"Niwano","year":"2003","journal-title":"Circ Res: J Am Hear Assoc"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0127","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/vetsci11040155","article-title":"Effects of beraprost with or without NOS inhibition on plasma aldosterone and hemodynamics in healthy cats","volume":"11","author":"Matsuura","year":"2024","journal-title":"Vet Sci"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jvim.16361","article-title":"Characterization of the intrarenal renin-angiotensin system in cats with naturally occurring chronic kidney disease","volume":"36","author":"Louren\u00e7o","year":"2022","journal-title":"J Vet Intern Med"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jvp.12848","article-title":"Aldosterone and the mineralocorticoid receptor in renal injury: a potential therapeutic target in feline chronic kidney disease","volume":"43","author":"Spencer","year":"2020","journal-title":"J Vet Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0130","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/0300985813516645","article-title":"Renal morphology in cats with diabetes mellitus","volume":"51","author":"Zini","year":"2014","journal-title":"Vet Pathol"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/00912709922007903","article-title":"DHEA and DHEA-S: a review","volume":"39","author":"Kroboth","year":"1999","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0132","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.24660","article-title":"In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system","volume":"13","author":"Mannic","year":"2018","journal-title":"Int J Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.domaniend.2025.106955_bib0133","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0047-6374(01)00393-1","article-title":"Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S","volume":"123","author":"Nawata","year":"2002","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.domaniend.2025.106955_bib0134","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.vh.2018.02.003","article-title":"Mechanisms of action of dehydroepiandrosterone","volume":"108","author":"Clark","year":"2018","journal-title":"Vitam Horm"},{"issue":"2\u20133","key":"10.1016\/j.domaniend.2025.106955_bib0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vph.2007.12.002","article-title":"Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of ppar\u03b1 and NF-\u03bab","volume":"48","author":"Altman","year":"2008","journal-title":"Vasc Pharmacol"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0136","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/HYPERTENSIONAHA.111.171280","article-title":"Dehydroepiandrosterone-induced phosphorylation and translocation of FoxO1 depend on the mineralocorticoid receptor","volume":"58","author":"Lindschau","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0137","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1099-0844(199803)16:1<57::AID-CBF771>3.0.CO;2-S","article-title":"Oxygen free radical scavenger properties of dehydroepiandrosterone","volume":"16","author":"Tamagno","year":"1998","journal-title":"Cell Biochem Funct"},{"issue":"13","key":"10.1016\/j.domaniend.2025.106955_bib0138","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.steroids.2011.08.002","article-title":"Hydrogen peroxide signaling mediates DHEA-induced vascular endothelial cell proliferation","volume":"76","author":"Iruthayanathan","year":"2011","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0139","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0024-3205(03)00287-X","article-title":"Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation","volume":"73","author":"Mastrocola","year":"2003","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00925945","article-title":"Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA)","volume":"131","author":"Kalimi","year":"1994","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"10.1016\/j.domaniend.2025.106955_bib0141","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/bph.13097","article-title":"DHEA modulates the effect of cortisol on RACK1 expression via interference with the splicing of the glucocorticoid receptor","volume":"172","author":"Pinto","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.domaniend.2025.106955_bib0142","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fendo.2019.00886","article-title":"Dehydroepiandrosterone and its CYP7B1 metabolite 7\u03b1-hydroxydehydroepiandrosterone regulates 11\u03b2-hydroxysteroid dehydrogenase 1 directions in rat leydig cells","volume":"10","author":"Zhu","year":"2020","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0143","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1681\/ASN.2007030263","article-title":"DHEA induces 11\u03b2-HSD2 by acting on CCAAT\/enhancer-binding proteins","volume":"19","author":"Balazs","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.domaniend.2025.106955_bib0144","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.2042-7158.1998.tb03325.x","article-title":"Drug metabolism: activation of 11 \u03b2-hydroxysteroid dehydrogenase by dehydroepiandrosterone sulphate as an anti-hypertensive agent in spontaneously hypertensive rats","volume":"50","author":"Homma","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.domaniend.2025.106955_bib0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biochi.2021.03.010","article-title":"DHEA-pretreatment attenuates oxidative stress in kidney-cortex and liver of diabetic rabbits and delays development of the disease","volume":"185","author":"Kiersztan","year":"2021","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0146","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000224629","article-title":"Dehydroepiandrosterone pretreatment alters the ischaemia\/reperfusion-induced VEGF, IL-1 and IL-6 gene expression in acute renal failure","volume":"32","author":"Vannay","year":"2009","journal-title":"Kidney Blood Press Res"},{"issue":"10","key":"10.1016\/j.domaniend.2025.106955_bib0147","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jdi.13862","article-title":"Correlation of dehydroepiandrosterone with diabetic nephropathy and its clinical value in early detection","volume":"13","author":"Ma","year":"2022","journal-title":"J Diabetes Investig"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0148","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jcem-51-4-801","article-title":"Subnormal plasma adrenal androgen levels in men with uremia*","volume":"51","author":"Zumoff","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0149","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2005.11.006","article-title":"Low serum dehydroepiandrosterone sulfate concentration is a predictor for deterioration of urinary albumin excretion in male patients with type 2 diabetes","volume":"73","author":"Fukui","year":"2006","journal-title":"Diabetes Res Clin Pr"},{"key":"10.1016\/j.domaniend.2025.106955_bib0150","article-title":"Low serum dehydroepiandrosterone is associated with diabetic kidney disease in men with type 2 diabetes mellitus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0151","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11306-020-01762-3","article-title":"Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore longitudinal study of aging","volume":"17","author":"Yamaguchi","year":"2021","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0152","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ajh.2008.307","article-title":"Inverse associations between androgens and renal function: the young men cardiovascular association (YMCA) Study","volume":"22","author":"Tomaszewski","year":"2009","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0153","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1523-1755.2004.00497.x","article-title":"Testosterone promotes apoptotic damage in human renal tubular cells","volume":"65","author":"Verzola","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.domaniend.2025.106955_bib0154","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/01.HYP.0000099241.53121.7F","article-title":"Role of androgens in mediating renal injury in aging SHR","volume":"42","author":"Fortepiani","year":"2003","journal-title":"Hypertens: J Am Hear Assoc"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0155","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1210\/jcem.83.6.4876","article-title":"Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro : possible link between endocrinosenescence and immunosenescence","volume":"83","author":"Straub","year":"1998","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0156","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.steroids.2011.02.006","article-title":"The effect of dehydroepiandrosterone (DHEA) on renal function and metabolism in diabetic rats","volume":"76","author":"Jahn","year":"2011","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0157","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.domaniend.2011.11.001","article-title":"Altered plasma concentrations of sex hormones in cats infected by feline immunodeficiency virus or feline leukemia virus","volume":"42","author":"Tejerizo","year":"2012","journal-title":"Domest Anim Endocrin"},{"issue":"18","key":"10.1016\/j.domaniend.2025.106955_bib0158","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180075","article-title":"The impact of sex on HIV immunopathogenesis and therapeutic interventions","volume":"134","author":"Mihealsick","year":"2024","journal-title":"J Clin Investig"},{"issue":"3\u20134","key":"10.1016\/j.domaniend.2025.106955_bib0161","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-2427(03)00081-3","article-title":"16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression","volume":"94","author":"Pedersen","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0162","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2265.2001.01310.x","article-title":"Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease","volume":"55","author":"Piketty","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.domaniend.2025.106955_bib0163","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj0890051","article-title":"Urinary steroids of cats. I. ABSENCE of 17-oxo steroids","volume":"89","author":"Borrell","year":"1963","journal-title":"Biochem J"},{"issue":"03","key":"10.1016\/j.domaniend.2025.106955_bib0164","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0029-1210342","article-title":"Serum levels of testosterone precursors, testosterone and estradiol in 10 animal species","volume":"83","author":"Wichmann","year":"1984","journal-title":"Exp Clin Endocrinol"},{"key":"10.1016\/j.domaniend.2025.106955_bib0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cca.2014.08.023","article-title":"Simultaneous measurement of testosterone, androstenedione and dehydroepiandrosterone (DHEA) in serum and plasma using isotope-dilution 2-dimension ultra high performance liquid-chromatography tandem mass spectrometry (ID-LC\u2013MS\/MS)","volume":"438","author":"B\u00fcttler","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0166","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2164\/jandrol.108.005561","article-title":"Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men","volume":"29","author":"Friedrich","year":"2008","journal-title":"J Androl"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0167","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/JOE-12-0246","article-title":"In the zone: understanding zona reticularis function and its transformation by adrenarche","volume":"214","author":"Bird","year":"2012","journal-title":"J Endocrinol"},{"key":"10.1016\/j.domaniend.2025.106955_bib0168","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fnins.2016.00238","article-title":"Functional zonation of the adult mammalian adrenal cortex","volume":"10","author":"Vinson","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.domaniend.2025.106955_bib0169","unstructured":"Physiology, catecholamines - StatPearls - NCBI bookshelf. Accessed October 8, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507716\/#:\u223c:text=Dopamine,%20norepinephrine,%20and%20epinephrine%20are%20physiologically%20active%20molecules."},{"issue":"3\u20134","key":"10.1016\/j.domaniend.2025.106955_bib0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000181816","article-title":"Catecholamines and blood pressure regulation","volume":"34","author":"Mannelli","year":"1990","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.domaniend.2025.106955_bib0171","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.566871","article-title":"Role of \u03b12-adrenoceptors in hypertension: focus on renal sympathetic neurotransmitter release, inflammation, and sodium homeostasis","volume":"11","author":"Hering","year":"2020","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0172","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/01.HYP.5.4.545","article-title":"Elevated plasma catecholamines in hypertensives with primary glomerular diseases","volume":"5","author":"Ishii","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0173","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1997.103","article-title":"Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure","volume":"51","author":"Ye","year":"1997","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0174","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1681\/ASN.2012070678","article-title":"Renal nerves drive interstitial fibrogenesis in obstructive nephropathy","volume":"24","author":"Kim","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.domaniend.2025.106955_bib0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.HYP.38.3.353","article-title":"Enhanced interaction between renovascular \u03b12-adrenoceptors and angiotensin II receptors in genetic hypertension","volume":"38","author":"Jackson","year":"2001","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.domaniend.2025.106955_bib0176","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.ASN.0000045049.72965.B7","article-title":"Enalapril and Losartan reduce sympathetic hyperactivity in patients with chronic renal failure","volume":"14","author":"Klein","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.domaniend.2025.106955_bib0177","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1113\/jphysiol.1971.sp009368","article-title":"Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs","volume":"213","author":"Hall","year":"1971","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0178","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jsap.13601","article-title":"Diagnosis, treatment and outcome of pheochromocytoma in a cat","volume":"64","author":"Prego","year":"2023","journal-title":"J Small Anim Pr"},{"issue":"6","key":"10.1016\/j.domaniend.2025.106955_bib0179","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jfms.2009.10.010","article-title":"Plasma free metanephrines in healthy cats, cats with non-adrenal disease and a cat with suspected phaeochromocytoma","volume":"12","author":"Wimpole","year":"2009","journal-title":"J Feline Med Surg"},{"issue":"4","key":"10.1016\/j.domaniend.2025.106955_bib0180","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2460\/ajvr.67.4.731","article-title":"Evaluation of the effects of stress in cats with idiopathic cystitis","volume":"67","author":"Westropp","year":"2006","journal-title":"Am J Vet Res"},{"issue":"6, Part 1 of 2","key":"10.1016\/j.domaniend.2025.106955_bib0181","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0022-5347(05)66292-1","article-title":"Increased plasma norepinephrine concentration in cats with interstitial cystitis","volume":"165","author":"Buffington","year":"2001","journal-title":"J Urology"}],"container-title":["Domestic Animal Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073972402500044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073972402500044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T15:42:07Z","timestamp":1756654927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073972402500044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":179,"alternative-id":["S073972402500044X"],"URL":"https:\/\/doi.org\/10.1016\/j.domaniend.2025.106955","relation":{},"ISSN":["0739-7240"],"issn-type":[{"type":"print","value":"0739-7240"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the gap\u2014Rethinking the role of the adrenal gland in chronic kidney disease from the feline perspective","name":"articletitle","label":"Article Title"},{"value":"Domestic Animal Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.domaniend.2025.106955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106955"}}